• Cy5-UTP for RNA Labeling: Protocols, Use-Cases, and Troubles

  2026-05-12

  Cy5-UTP (Cyanine 5-UTP) delivers robust, high-sensitivity fluorescent RNA labeling for FISH, dual-color arrays, and single-molecule imaging. This guide unpacks workflow optimizations, troubleshooting, and new insights from single-molecule collision studies to maximize your RNA detection power.

• TH287 MTH1 Inhibitor: Advancing Radiosensitization in CRPC

  2026-05-11

  Explore the mechanistic underpinnings and translational strategy behind TH287, a potent MTH1 inhibitor, for radiosensitizing castration-resistant prostate cancer (CRPC) cells. This thought-leadership article integrates new evidence, protocol guidance, and product insights to empower researchers pursuing precision oncology breakthroughs.

• ABT-263 (Navitoclax): Applied Workflows in Apoptosis Assays

  2026-05-11

  ABT-263 (Navitoclax) empowers apoptosis and cancer biology research with unparalleled specificity for Bcl-2 family proteins, enabling reliable caspase-dependent apoptosis assays. This guide translates recent evidence and expert workflow insights into actionable steps, troubleshooting, and protocol enhancements—driving robust results for oncology and senescence studies.

• Azithromycin: Macrolide Antibiotic Workflows and Optimizatio

  2026-05-10

  Azithromycin’s unique inhibition of bacterial protein synthesis makes it indispensable for bacterial infection research, resistance screening, and trypanosomosis animal models. This guide dissects advanced, data-driven workflows and troubleshooting insights to help researchers fully leverage APExBIO’s Azithromycin for superior reproducibility and translational impact.

• Cyclophilin A and Cyclosporine: Dissecting Immunosuppressive

  2026-05-09

  This study reveals that cyclophilin A is indispensable for cyclosporine-mediated immunosuppression, showing that mice deficient in cyclophilin A resist cyclosporine’s effects. These findings clarify the molecular basis of immunosuppressive selectivity and have direct implications for the design and interpretation of T-cell assays and transplantation immunology research.

• Tamsulosin for Urological Research: Applied Workflows & Opti

  2026-05-08

  Tamsulosin unlocks new benchmarks in urological and smooth muscle relaxation research, offering quantified advantages for stone expulsion and postoperative urinary retention models. Robust solubility and selective α₁A antagonism empower reproducible, high-impact experimental design. This guide translates meta-analytic evidence into streamlined protocols and troubleshooting strategies.

• SLC25A1 Drives Cisplatin Resistance in HNSCC via Cellular Se

  2026-05-08

  Li et al. reveal that upregulation of SLC25A1 promotes cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) through H3K27 acetylation-mediated cellular senescence. Their mechanistic findings identify SLC25A1 as a predictive biomarker and potential therapeutic target for chemoresistant HNSCC.

• Cefazedone (Refosporen): Applied Workflows & Experimental Ma

  2026-05-07

  Cefazedone (Refosporen) brings robust, β-lactamase-resistant efficacy to microbiology labs and translational pipelines, enabling precise antibacterial testing and optimized clinical regimens. This guide details reproducible workflows, troubleshooting strategies, and evidence-backed innovations for researchers targeting Gram-positive and Gram-negative pathogens.

• PK/PD Cutoffs and Dose Optimization of Macrolides for H. par

  2026-05-07

  Zhou et al. established epidemiological and PK/PD cutoff values and evaluated optimal dosing regimens for gamithromycin against Haemophilus parasuis in piglets. Their integration of ex vivo PK/PD modeling with large-scale MIC data provides crucial benchmarks for antimicrobial resistance surveillance and dose selection in veterinary infection research.

• Amyloid β-Peptide (1-42) (human): Decoding Microglial Modula

  2026-05-06

  Explore how Amyloid β-Peptide (1-42) modulates microglial phagocytosis and neuronal ion channels, with a focus on mechanistic insights for Alzheimer's disease research. This article unpacks new translational perspectives for advanced assay design.

• Abiraterone Acetate in Translational Prostate Cancer Models

  2026-05-06

  Explore how Abiraterone acetate, a leading CYP17 inhibitor, enables advanced mechanistic research in castration-resistant and organ-confined prostate cancer models. Uniquely, this article integrates molecular pharmacology with recent breakthroughs in 3D patient-derived spheroid assays for superior experimental design.

• Caspase-3 and ERO1α Drive Trichothecene-Induced Mitochondria

  2026-05-05

  This study reveals a mechanistic link between caspase-3-mediated NDUFS1 cleavage and ERO1α activity in driving excessive mitochondrial and ER-derived ROS during trichothecene exposure. These findings clarify the molecular underpinnings of mycotoxin-induced hepatotoxicity and highlight new targets for redox intervention.

• GSTA1 Drives Glutathione Depletion in α-Amanitin Hepatotoxic

  2026-05-05

  This study uncovers a paradoxical role for GSTA1 in α-amanitin-induced liver injury, demonstrating that its upregulation exacerbates oxidative stress by depleting glutathione reserves. The findings reposition GSTA1 from detoxifier to a pathogenic mediator, highlighting new avenues for therapeutic intervention and biomarker development in acute hepatotoxicity.

• CHIR-99021 (CT99021): Strategic Advances in Translational Re

  2026-05-04

  Explore how CHIR-99021 (CT99021), a highly selective GSK-3 inhibitor, is redefining experimental strategies for translational researchers. This thought-leadership article blends mechanistic insights into Wnt/β-catenin and TGF-β/Nodal modulation with evidence-based guidance on protocol optimization, competitive benchmarking, and future clinical implications. Directly referencing cutting-edge findings on regulated cell death and drawing from the latest workflow resources, it provides a strategic roadmap for leveraging CHIR-99021 in pluripotency maintenance, directed differentiation, and vascular disease modeling.

• Vincristine Sulfate: Optimizing Microtubule Disruption in Ca

  2026-05-04

  Vincristine sulfate offers reproducible, high-impact microtubule disruption for cancer research, enabling robust cell viability and in vivo tumor delay assays. This guide translates bench-validated workflows and troubleshooting insights into actionable steps for maximizing experimental success with APExBIO’s rigorously characterized reagent.

16651 records 1/1111 page Next 12345 下5页 Last page